GWAS |
- Apolipoprotein B levels ( 32203549)
- Asthma exacerbations in inhaled corticosteroid treatment ( 30697902)
- Cholesterol, total ( 24097068)
- Diisocyanate-induced asthma ( 25918132)
- Femoral neck bone mineral density ( 30172743)
- LDL cholesterol ( 20864672 24097068 25961943)
- LDL cholesterol levels ( 32203549 30698716 28334899)
- LDL cholesterol levels in current drinkers ( 30698716)
- LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- Major depressive disorder ( 23377640)
- Medication use (HMG CoA reductase inhibitors) ( 31015401)
- Response to statins (LDL cholesterol change) ( 22331829)
- Total cholesterol levels ( 28334899)
|
- Blood protein levels ( 30072576)
- Body mass index (alcohol intake interaction) ( 23192594)
- Brain morphology (min-P) ( 32665545)
- Brain morphology (MOSTest) ( 32665545)
- Cerebrospinal fluid AB1-42 levels ( 28247064)
- Cortical surface area (min-P) ( 32665545)
- Cortical surface area (MOSTest) ( 32665545)
- Cortical thickness (min-P) ( 32665545)
- Cortical thickness (MOSTest) ( 32665545)
- General risk tolerance (MTAG) ( 30643258)
- Number of sexual partners ( 30643258)
- Subcortical volume (min-P) ( 32665545)
- Subcortical volume (MOSTest) ( 32665545)
- Type 2 diabetes nephropathy ( 30566433)
- Urinary metabolite levels in chronic kidney disease ( 31959995)
|